Genetically susceptible mice remain proportionally more susceptible to tuberculosis after vaccination

Immunology

Volumn 96, Issue 1, 1999, Pages 16-21

  Medina, E ^a   North, R J ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BCG VACCINATION; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE PREDISPOSITION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME; TUBERCULOSIS;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; LIVER; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; TUBERCULOSIS; VACCINATION;

EID: 0032942535     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00663.x     Document Type: Article

References (15)

1. 1. KAUFMANN S.H.E. (1990) Vaccines against tuberculosis: the impact of modern technology. Scand J Infect Dis Suppl. 76, 54.
2. 2. ORME I.M. (1997) Progress in the development of new vaccines against tuberculosis. Int J Tuberc Lung Dis 1, 95.
3. 3. DUNN P.L. & NORTH R.J. (1995) Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect Immun 63, 3428.
4. 4. FARER L.S., LOWELL A.M. & MEADOR M.P. (1979) Extrapulmonary tuberculosis in the United States. Am J Epidemiol 109, 205.
5. 5. BARNES P.F., BLOCH A.B., DAVIDSON P.T. & SNIDER D.E. (1991) Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 324, 1644.
6. 6. MEDINA E. & NORTH R.J. (1996) Evidence inconsistent with a role for the Beg gene (Nrampl) in resistance of mice to infection with Mycobacterium tuberculosis. J Exp Med 183, 1045.
7. 7. ELLIS R.C. & ZABROWARNY L.A. (1993) Safer staining method for acid fast bacilli. J Clin Pathol 46, 559.
8. 8. RICH A.R. (1951) The pathogenesis of tuberculosis. p. 823. Charles C. Thomas, Springfield, IL.
9. 9. ORME I.A., ANDERSEN P. & BOOM W.H. (1993) T cell response to Mycobacterium tuberculosis. J Infect Dis 167, 1481.
10. 10. BOOM W.H. (1996) The role of T cell subsets in Mycobacterium tuberculosis infection. Infect Agents Dis 5, 73.
11. 11. MALO D., VOGAN K., VIDAL S. et al. ( 1994) Haplotype mapping and sequence analysis of the mouse Nramp gene predicts susceptibility to infection with intracellular parasites. Genomics 23, 51.
12. 12. FORGET A. & SKAMENE E. (1985) Genetic regulation of early host defense mechanisms controlling mycobacterial infection. In: Genetic Control of Host Resistance to Infection and Malignancy (Ed. E. SKAMENE), p. 265. Alan R. Liss, Inc., New York.
13. r inbred mouse strains infected with a low dose of BCG Montreal. Clin Exp Immunol 56, 81.
14. 14. DUNN P.L. & NORTH R.J. (1996) Persistent infection with virulent but not avirulent Mycobacterium tuberculosis in the lungs of mice causes progressive pathology. J Med Microbiol 45, 103.
15. 15. LOWRIE D.B., SILVA C.L. & TASCON R.E. (1997) DNA vaccines against tuberculosis. Immunol Cell Biol 75, 591.